Evidence map›Paper›PMID 33255676›Full record

ArticleMicroorganisms2020

Application of Erythromycin and/or

Mariusz Cycoń, Anna Markowicz, Tomasz J Wąsik, Zofia Piotrowska-Seget

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mariusz CycońDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.ORCID 0000-0002-7865-6371
Anna MarkowiczInstitute of Biology, Biotechnology and Environmental Protection, Faculty of Natural Sciences, University of Silesia, Jagiellońska 28, 40-032 Katowice, Poland.
Tomasz J WąsikDepartment of Microbiology and Virology, Faculty of Pharmaceutical Sciences, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.ORCID 0000-0001-6525-9767
Zofia Piotrowska-SegetInstitute of Biology, Biotechnology and Environmental Protection, Faculty of Natural Sciences, University of Silesia, Jagiellońska 28, 40-032 Katowice, Poland.ORCID 0000-0002-9039-2268
Medical University of Silesia · PLUniversity of Silesia in Katowice · PL

Funding

Śląski Uniwersytet Medyczny KNW-1-1-073/N/7/L
6 · The paper itself

Abstract

Erythromycin (EM), a macrolide antibiotic, by influencing the biodiversity of microorganisms, might change the catabolic activity of the entire soil microbial community. Hence, the goal of this study was to determine the metabolic biodiversity in soil treated with EM (1 and 10 mg/kg soil) using the community-level physiological profiling (CLPP) method during a 90-day experiment. In addition, the effect of soil inoculation with antibiotic-resistant

Indexed as

catabolic activityerythromycinRaoultella sp.soil microorganismsthe community-level physiological profiling (CLPP)the resistance (RS)/resilience (RL) concept

Identifiers

PMID33255676
PMCPMC7760179
OpenAlexW3110530765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.